Medpace Holdings Inc

MEDP is exhibiting signs of a mean-reversion bounce as it tests the rising 200-day SMA near oversold conditions. The Bearish Exhaustion pattern indicates sellers are losing control, suggesting a potential medium-term bottom. Short-term, price remains below the 9- and 20-EMAs, warranting patience for a cleaner pullback entry. Overall, structural context supports deferred bullish engagement on pullbacks into the $570–$580 support zone.

• ↑Q4 2025 revenue $708.5 M, +32% YoY
• ↑Q4 net new awards +39.1% YoY; book-to-bill ratio 1.04
• ↓Q4 cancellations remained high; net book-to-bill at 1.04 risks momentum